Massachusetts · Bill 945 · 193rd General Court

An Act to ensure prescription drug cost transparency and affordability

  1. Introduced Feb 16, 2023
  2. In committee Feb 16, 2023
  3. Failed  
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

By Representatives Barber of Somerville and Santiago of Boston, a petition (accompanied by bill, House, No. 945) of Christine P. Barber, Jon Santiago and others for legislation to ensure prescription drug cost transparency and affordability. Financial Services.

Every action

5 steps, oldest first, as the legislature records them.

  1. CommitteeReferred to the committee on Financial Services · Joint Committee on Financial Services
  2. SenateSenate concurred
  3. CommitteeHearing scheduled for 05/16/2023 from 10:00 AM-01:00 PM in A-2 and virtual · Joint Committee on Financial Services
  4. CommitteeReported favorably by committee and referred to the committee on Health Care Financing · Joint Committee on Health Care Financing
  5. HouseAccompanied a study order, see H4634

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it, joined by 28 cosponsors: 25 Democrats, 2 Republicans, 1 Independent.

All 28 cosponsors

From Massachusetts's official records (malegislature.gov/api), checked Nov 14, 2026. Text links go to the official versions; LegiList does not copy bill text.